Corporate calendar for Novavax, Inc. (NVAX): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Novavax, Inc. is a biotechnology firm dedicated to discovering, developing, and commercializing vaccines aimed at preventing serious infectious diseases and addressing critical health needs. The company's diverse pipeline includes NVX-CoV2373, a coronavirus vaccine candidate currently undergoing two Phase III trials, one Phase IIb, and one Phase I/II trial. Also featured is NanoFlu, a nanoparticle-based seasonal quadrivalent influenza vaccine in Phase 3 clinical trials.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | $0.18 | $557M |
| 2026-09-14 | $144M | |
| 2026-09-14 | $0.03 | $3M |
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 |
Stock Splits
| Date | Ratio |
|---|---|
| 2019-05-10 | 1:20 |
Price
| Price | $9.35 |
| Market Cap | $1.5B |
| Exchange | NASDAQ |
| Country | US |
Related companies: CVAC · NKTR · NTLA · ORIC · PGEN · TERN · TRVI
Explore sector: Healthcare · Biotechnology
More sections of NVAX: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks